Pappas Capital is a global venture capital and commercial development firm focused on advancing life science, agriculture, and technology companies. It operates through three main business lines: Pappas Ventures, which is the firm's flagship life science venture arm; Specialized Fund Management, which creates and manages custom-tailored investment vehicles; and Translational Medicine, which partners with research universities to expedite the development of scientific discoveries and inventions.

Pappas Ventures 1

Pappas Ventures II

Founded in 1994, Pappas Capital is a global venture capital and commercial development firm that specializes in investments in next-generation life science, agriculture, and technology companies across the United States and Canada, with select investments in Asia and Europe.

Whether you’re looking for capital or have capital to invest, contact us and learn how we can put our expertise to work for you.



Cyclerion Therapeutics

VelosBio

Milestone Pharmaceuticals

Mirum Pharmaceuticals

Reneo Pharmaceuticals

BioAtla

4D Molecular Therapeutics

Amplyx Pharmaceuticals

Athersys

Pappas Capital

COM:PAPPAS-CAPITAL

Pappas Capital

Analysis Not Available